Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Language
Document Type
Year range
1.
The Egyptian journal of immunology ; 30(1):31-41, 2023.
Article in English | EMBASE | ID: covidwho-2167364

ABSTRACT

Since the start of the pandemic, the number of cases has been increased rapidly. Due to asymptomatic and mild cases and restricted testing in many geographic locations, the overall number of actual COVID-19 cases is likely significantly higher than the number of verified cases. Several COVID-19-related comorbid diseases impair immune system function, which has an impact on COVID-19 responsiveness. So, we evaluated the immune response to SARS-CoV-2 after the third wave of COVID-19 and assessed the effect of comorbid diseases on this immune response. The current cross-sectional study was conducted in August 2021 after the third wave of COVID-19. The study included 287 participants. All participants were asked about their epidemiological data, comorbid diseases, data suggesting COVID-19 infection, and precautions measures to minimize the exposure to the disease. Of the 278 participants, 50% had a positive IgG response to COVID-19. Regarding comorbid diseases, the IgG antibody titer was significantly lower in patients with chronic kidney diseases (CKD) on dialysis, ischemic heart disease, and chronic obstructive lung diseases than other participants (p= 0.01, p= 0.02, p= 0.005, respectively). Neither precaution measures nor comorbid diseases had a role in risk factors of COVID-19 infections in our participants. In conclusion, high seroprevalence (50%) of SARS-CoV-2 IgG antibody after the third wave of COVID-19 was observed in the current study. Comorbid conditions as hypertension, chronic cardiac diseases, chronic chest problems, and CKD on dialysis could decrease the immune response against COVID-19 infection. Copyright© by the Egyptian Association of Immunologists.

2.
International Conference on Business and Technology , ICBT 2021 ; 495 LNNS:1000-1010, 2023.
Article in English | Scopus | ID: covidwho-1971481

ABSTRACT

This research aimed to clarify the impact of the application of IFRS 9 standard on the financial performance of Jordanian Commercial Banks (JCB) under the Corona pandemic, to achieve the goal of this research Descriptive analytical method was used the Population consisted Of all Jordanian commercial banks, While the research sample consisted of the following commercial banks (Housing Bank, Arab Bank, Jordan Bank, Jordan Kuwaiti Baank, union Bank and Cairo Amman Bank) during the period of 2018 till the end of the third quarter of 2021 where the owners’ equity was used to select the research simple and SPSS was used to analyze the research data. The financial performance was measured through financial indicators (profitability, financial strength, liquidity, financial risks), and the independent financial variable was measured through the provision for declining credit facilities and government accounts. One of the most prominent results of the research in the level of significance (α ≤ 0.05) and the trademark (9) IFRS on the financial performance of JCB in light of the Corona pandemic. In addition, the atmosphere of the exemplary research in postgraduate studies and benefit from the application of the IFRS (9) criterion as much as possible, in addition to following up on updates and amendments on a regular basis. © 2023, The Author(s), under exclusive license to Springer Nature Switzerland AG.

SELECTION OF CITATIONS
SEARCH DETAIL